Byline: Nora Dunne
-
Mechanism Behind Chronic Fibrosis Discovered
Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.
-
Meltzer Honored for Contributions to Psychopharmacology
Herbert Meltzer, MD, professor of Psychiatry and Behavioral Sciences, Pharmacology and Physiology, has been chosen to receive a Pioneer in Psychopharmacology Award from the International College of Neuropsychopharmacology.
-
New Drug Clears Psoriasis in Clinical Trials
Patients with psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab in three recent clinical trials led by a Northwestern Medicine investigator
-
Balancing Gene Expression to Prevent Disease
Northwestern Medicine scientists explore research that has shown how the balanced activities of two protein families regulate gene expression during embryonic development and how mutations that tip this balance lead to cancer.
-
New Gene Shown to Cause Parkinson’s Disease
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
-
Student Analyzes Epidemiology of Rare Skin Disorders
Medical student Derek Hsu studies the incidence and outcomes of rare skin disorders in order to develop predictors of mortality, information that could help clinicians prevent and treat the conditions.
-
Targeting Immune Cell Trafficking in Colon Disease
A new drug safely and effectively treats patients with ulcerative colitis, according to a recent study co-authored by Northwestern Medicine investigator Stephen Hanauer, MD.
-
Chandel Awarded NCI Outstanding Investigator Award
Navdeep Chandel, PhD, David W. Cugell Professor of Medicine, has received the National Cancer Institute’s Outstanding Investigator Award to explore how mitochondrial metabolism plays a role in cancer.
-
Evaluating an Alternative to Open-Heart Surgery
A minimally invasive procedure to repair aortic stenosis may be preferable to open-heart surgery when treating patients at intermediate risk of surgical mortality, according to recent research.
-
Residents Investigate Regulation of Women’s Health Devices
Some high-risk medical devices used in obstetrics and gynecology were approved by the FDA based on flawed data, according to a recent study conducted by Northwestern Medicine residents.
